Molecular genetic markers in predicting the clinical course of cervical cancer according to data from the Samarkand regional branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology
Keywords:
ranks, fourth, developingAbstract
Cervical cancer (CC) remains a global health problem, particularly in developing countries. According to GLOBOCAN 2022, 604,000 new cases and 342,000 deaths from CC were recorded worldwide in 2020. In the structure of oncological morbidity and mortality in women worldwide, cervical cancer ranks fourth, and in developing countries this type of oncological pathology ranks first, while in economically developed countries it ranks third after uterine and ovarian cancer.
References
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
